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Abstract. 
 
The p21 (Cdc42/Rac) activated kinase Pak1 
regulates cell morphology and polarity in most, if not 
all, eukaryotic cells. We and others have established 
that Pak’s effects on these parameters are mediated by 
changes in the organization of cortical actin. Because 
cell motility requires polarized rearrangements of the 
actin/myosin cytoskeleton, we examined the role of 
Pak1 in regulating cell movement. We established 
clonal tetracycline-regulated NIH-3T3 cell lines that in-
ducibly express either wild-type Pak1, a kinase-dead, or 
constitutively-active forms of this enzyme, and exam-
ined the morphology, F-actin organization, and motility 
of these cells. Expression of any of these forms of Pak1 
induced dramatic changes in actin organization which 
were not inhibited by coexpression of a dominant-nega-
tive form of Rac1. Cells inducibly expressing wild-type 
or constitutively-active Pak1 had large, polarized lamel-
lipodia at the leading edge, were more motile than their 
normal counterparts when plated on a ﬁbronectin-
coated surface, and displayed enhanced directional 
movement in response to an immobilized collagen gra-
dient. In contrast, cells expressing a kinase-dead form 
of Pak1 projected multiple lamellipodia emerging from 
different parts of the cell simultaneously. These cells, 
though highly motile, displayed reduced persistence of 
movement when plated on a ﬁbronectin-coated surface 
and had defects in directed motility toward immobi-
lized collagen. Expression of constitutively activated 
Pak1 was accompanied by increased myosin light chain 
(MLC) phosphorylation, whereas expression of kinase-
dead Pak1 had no effect on MLC. These results suggest 
that Pak1 affects the phosphorylation state of MLC, 
thus linking this kinase to a molecule that directly af-
fects cell movement.
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M
 
ANY
 
 cell types are induced to move in response
to external factors. Cell migration is essential
during embryonic development, in immune re-
sponse, and wound healing, and aberrant motility is a hall-
mark of metastatic cells. The migration of fibroblasts in
vitro requires acquisition of spacial asymmetry with the
extension of lamellipodia, attachment of the cytoskeleton
to the extracellular matrix, and generation of force that
propels the cell forward while pulling the attachments
rearward (Sheetz, 1994). Actin polymerization is thought
to drive the formation and extension of the lamellipodial
leading edge, while the activation of myosin, particularly
 
myosin II, is thought to be at least partially responsible
for creating the traction force needed for cell movement
(Condeelis, 1993). In addition, the strength and dynamics
of focal adhesion formation play a major role in cell loco-
motion. The molecular basis of the signaling steps that reg-
ulate motile responses are poorly understood; however,
Ras and related GTPases of the Rho family clearly play
important roles in this process. For example, the scattering
response of MDCK cells in response to HGF can be abol-
ished by dominant negative Ras, Rac1, as well as constitu-
tively active RhoA (Ridley et al., 1995), and activated
forms of Rac1 and Cdc42 can increase cell motility and the
invasive potential of epithelial cells (Keely et al., 1997;
Sander et al., 1998). In addition, Rac1 modulates growth
factor–driven chemotaxis in fibroblasts and macrophages
(Anand-Apte et al., 1997; Allen et al., 1998).
Reorganization of the actin cytoskeleton is a prerequi-
site for cell motility. The Rho GTPases, Cdc42, Rac1, and
RhoA are well known for their ability to induce rearrange-
ments of filamentous actin. In the case of Cdc42 and Rac,
several candidate effectors have been identified that might
link these GTPases to the actin cytoskeleton. In mamma-
lian cells, these candidate effectors include (a) protein
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kinases, such as p21-activated kinases (Paks)
 
1
 
, myotonic-
dystrophy–related kinases, MEKKs, and mixed-lineage ki-
nases, (b) lipid kinases, such as PI3 kinase and PI5 kinase,
(c) formins, such as the mouse homologue of 
 
Diaphanous
 
(p140mDia), (d) actin binding proteins, such as IQGAPs,
and (e) other proteins that affect actin structure, such as
Wiskott-Aldrich protein and POR1 (reviewed in Van
Aelst and D’Souza-Schorey, 1997). A major point of con-
troversy in the literature is whether Paks have a role in
mediating F-actin assembly by these GTPases in mamma-
lian cells. On the one hand, mutants of Rac1 and Cdc42
that do not efficiently bind the three known mammalian
Paks are nonetheless able to induce characteristic actin re-
organization in fibroblasts (Joneson et al., 1996; Lamarche
et al., 1996; Westwick et al., 1997). On the other hand, ex-
pression of activated forms of Pak1 induces changes in ac-
tin and focal adhesion structure similar to those seen with
activated GTPases (Manser et al., 1997; Sells et al., 1997).
A possible resolution to these two seemingly conflicting
results has been provided recently by Manser et al., who
showed that Pak1 can be activated even in the absence of
direct binding to Cdc42 through interaction with the gua-
nine-nucleotide exchange factor PIX (Manser et al., 1998).
In lower eukaryotes, Paks clearly play a role in regulat-
ing actin-based morphogenic events. Deletion of the Pak
homologue 
 
STE20
 
 in budding yeast results in sterile cells,
unable to form mating projections or activate the tran-
scription program required for mating (Leberer et al.,
1992). Overexpression of 
 
STE20
 
 is sufficient to relieve the
morphological defects associated with loss of Cdc42p func-
tion, consistent with the postulated effector role for Ste20p
in regulating cortical actin assembly (Eby et al., 1998). In
this system, myosin I has been identified as a potential Pak
target (Wu et al., 1996, 1997), providing a possible expla-
nation for Pak’s morphogenic effects. In fission yeast, de-
letion and overexpression studies have shown that both
Pak1p and -2p regulate cell morphogenesis (Marcus et al.,
1995; Ottilie et al., 1995; Sells et al., 1998; Yang et al.,
1998). Interestingly, a temperature-sensitive mutation of
 
pak1
 
 was isolated recently during a screen for rounded
(
 
orb
 
) mutants of 
 
S
 
.
 
 pombe
 
 (Verde et al., 1995, 1998), pro-
viding independent evidence for a role for this protein in
morphogenesis. Genetic analysis has placed this gene
(
 
orb2
 
) upstream of another 
 
orb
 
 gene (
 
orb6
 
), which en-
codes a homologue of Rok, a Rho-activated kinase (Verde
et al., 1998). In vertebrates (Kimura et al., 1996) and prob-
ably in 
 
C
 
.
 
 elegans
 
 (Wissmann et al., 1997), Rok inactivates
myosin light chain (MLC) phosphatase, resulting in in-
creased MLC phosphorylation. Therefore, the observed
effects of 
 
S
 
.
 
 pombe
 
 Paks on cell morphology may involve
activation of MLC via Orb6p. Whether these findings will
extend to the mammalian system remains to be seen.
In a previous analysis, we noted that the majority of
Swiss 3T3 cells transiently expressing an activated form of
Pak1 developed large, polarized lamellipodia containing
 
numerous small focal complexes (Sells et al., 1997). Two
regions of Pak1 were found to be important for these cy-
toskeletal effects; proline-rich sequences in the NH
 
2
 
 termi-
nus, which bind to src-homology 3 (SH3) proteins such as
the adaptor Nck (Galisteo et al., 1996) and the guanine-
nucleotide exchange factor PIX (Manser et al., 1998), and
the COOH-terminal protein kinase domain (Manser et al.,
1997; Sells et al., 1997). The NH
 
2
 
-terminal proline-rich se-
quences appear to be important for Pak localization and
are required for the development of polarized lamellipo-
dia. The function of the kinase domain is less certain. Inac-
tivating mutations in the kinase domain do not abolish the
ability of Pak1 to reorganize actin, but cells expressing
such mutants have multiple protrusions and no apparent
leading edge (Sells et al., 1997). Therefore, the kinase do-
main of Pak1 may be important for the disposition of
lamellipodia.
The polarized phenotype induced by activated Pak1 is
reminiscent of that seen in motile fibroblasts. In this study,
we have analyzed the effects of Pak1 on cell motility, using
cell lines that inducibly express various forms of Pak1.
Here, we show that Pak1 induces the formation of leading
edge lamellipodia. These structures are not affected by co-
expression of a dominant-negative form of Rac1. Consis-
tent with this morphology, Pak1 overexpression stimulates
cell movement. Pak1 overexpression increases random cell
movement on fibronectin-coated surfaces, irrespective of
its protein kinase activity. In contrast, Pak1 also affects
directional cell movement toward an immobilized colla-
gen gradient, but this effect requires its kinase activity.
Activated forms of Pak1 induce MLC phosphorylation,
whereas a kinase-deficient mutant is without effect. These
results suggest that Pak1 plays a role in regulating direc-
tional cell motility through its effects on MLC.
 
Materials and Methods
 
Materials
 
Monoclonal anti-hemagglutinin (HA) antibody (12CA5) was obtained
from BabCo, polyclonal anti-Myc was obtained from Santa Cruz Biotech-
nology, Inc., and monoclonal anti-Myc antibody (9E10) was a gift from
Phil Tsichlis (Fox Chase Cancer Center, Philadelphia, PA). Antibodies
against activated Erk and Jnk were obtained from Promega Corp., anti-
vinculin was from Sigma Chemical Co., and anti–phospho-MLC (Mat-
sumura et al., 1998) was a kind gift from Fumio Matsumura (Rutgers Uni-
versity, New Brunswick, NJ). Fluorochrome-conjugated goat anti–mouse
and anti–rabbit antibodies were from Jackson ImmunoResearch Labora-
tories, Inc.
 
Expression Plasmids
 
Wild-type and mutant forms of Pak1 (Sells et al., 1997) were subcloned
from pJ3H (Sells and Chernoff, 1995) as SalI/(EcoRI 
 
®
 
 blunt) fragments
into SalI/EcoRV-cut pTet-Splice (Shockett et al., 1995). These plasmids
express NH
 
2
 
-terminal HA-tagged Pak1 when cells are grown in the absence
of tetracycline. The tetracycline-regulated expression vectors pUM-Rac1
V12 and pUM-Rac1 N17 (both Myc-tagged; Anand-Apte et al., 1997)
were kindly donated by Mark Symons (Onyx Corp., Richmond, CA).
 
Cell Culture
 
NIH-3T3 cells and derivatives were maintained in DME plus 10% calf se-
rum (CS). The NIH-3T3 variant S2-6 (Shockett et al., 1995), bearing a tet-
racycline-regulated transactivator, was used to construct cell lines that in-
ducibly express various forms of Pak1 or Rac1. To prepare stable,
regulated clonal cell lines, S2-6 cells were cotransfected with either pTet-
 
1. 
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ered saline; PDGF, platelet-derived growth factor; PI3, phosphatidyl ino-
sitol 3; PIX, Pak-interacting exchange factor; SH3, src-homology 3; SAPK,
stress-activated protein kinase. 
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Splice-Pak1 or pUM-Rac1 plasmids plus a plasmid encoding a puromycin
resistance gene using a calcium phosphate precipitation method (Chen
and Okayama, 1987). 48 h after transfection, the cells were selected in me-
dia containing 2.5 mM histidinol (to retain the tetracycline-VP16 transac-
tivator), 2 
 
m
 
g/ml puromycin (to select for the tetracycline-regulated ex-
pression vector), and 1 
 
m
 
g/ml tetracycline (to repress transgene expression
during selection). Clonal cell lines were isolated and expanded and at least
24 lines for each form of Pak1 or Rac1 were examined for inducible trans-
gene expression by anti-HA or anti-Myc immunoblot.
 
Immunoblots
 
Cells were lysed in NP-40 lysis buffer (50 mM Tris-HCl, pH 8.0, 137 mM
NaCl, 10% glycerol, 1% NP-40, 50 mM NaF, 10 mM 
 
b
 
-glycerol-phos-
phate) containing 1 mM sodium vanadate, 1 mM phenylmethylsulfonyl
fluoride, and 10 
 
m
 
g per ml aprotinin. 10 
 
m
 
g extract was fractionated by
10% SDS/PAGE and transferred to polyvinyl difluoride (Immobilon)
membranes. Membranes were blocked using fat-free milk, probed with
antibodies, and developed using an alkaline-phosphatase–based chemilu-
minescent system (Dupont/New England Nuclear).
 
Protein Kinase Assays
 
HA-tagged Pak1 was immunoprecipitated using mAb 12CA5 (BabCo)
from 35-mm wells of S2-6 cells grown in tetracycline-free DME. The im-
munoprecipitates were washed three times in NP-40 lysis buffer, once in
0.5 M LiCl, and then once in protein kinase buffer (50 mM Tris-HCl, pH
7.5, 10 mM MgCl
 
2
 
, 1 mM DTT). The immunoprecipitates were then incu-
bated at 30
 
°
 
C for 20 min in 25 
 
m
 
l protein kinase buffer containing 25 
 
m
 
M
ATP plus 5 
 
m
 
Ci 
 
g
 
-[
 
32
 
P]ATP. The reactions were stopped by the addition
of 5 
 
m
 
l 6
 
3
 
 SDS/PAGE sample buffer, boiled for 5 min, then separated by
10% SDS/PAGE. The dried gel was then autoradiographed.
 
Transient Transfection
 
Cells were plated at 3.2 
 
3
 
 10
 
5
 
 cells/35-mm culture dish in DME plus 10%
CS and transfected with expression plasmids using a calcium phosphate
precipitation method (Chen and Okayama, 1987).
 
Immunofluorescence Detection
 
Cells cultured on coverslips were fixed in 3.5% formaldehyde, permeabi-
lized in 0.1% Tween-20 and blocked with 3% BSA in PBS. After incuba-
tion with primary antibodies, the cells were stained with rhodamine
X-conjugated goat anti–rabbit antibodies along with AMCA-conjugated
and Cy5-conjugated anti–mouse antibodies. For staining of filamentous
actin, 0.1 
 
m
 
M Oregon Green or FITC-conjugated phalloidin was included
during incubation with the secondary antibodies. Confocal microscopy
was performed using a Bio-Rad MRC 600 laser scanning confocal micro-
scope.
 
Tetracycline Titration
 
Cells from one inducibly expressing clonal line for each of two constitutive
active mutant forms of Pak were plated at 30% confluence into 35-mm
wells with and without coverslips. 24 h later the cells were washed one
time in PBS and refed with DME plus 10% CS alone or with one of the
following: 1, 0.2, 0.1, 0.04, or 0.02 
 
m
 
g/ml tetracycline and incubated for an-
other 8 h. At that time, the cells were again washed and refed with DME
plus 0.2% CS, retaining the same tetracycline concentrations as 8 h ear-
lier. 16 h later, HA-tagged Pak was detected in the cells on coverslips by
indirect immunofluorescent staining, while the remaining cells were lysed
in NP-40 lysis buffer and immunoblotted as described above.
 
Motility Assays
 
Pak1 expression was induced by growth in tetracycline-free DME plus
10% CS for 16 h. After protein induction, the cells were treated with
trypsin, washed in the presence of soybean trypsin inhibitor and replated
in tetracycline-free DME plus 0.1% BSA onto plates coated with 1%
BSA for 30 min. Uninduced cells were treated in the same manner. The
cells were then transferred to a plate coated with 50 
 
m
 
g/ml fibronectin and
allowed to attach for 40 min. Phase contrast images were captured there-
after at 30-s intervals for calculation of cell speed and at 2-min intervals
for long term analysis (4 h sampling). The cells were tracked with the aid
of Isee™ imaging software and the results were tabulated using Excel™.
 
For measurements of haptotaxis, Pak1 expression was induced by
growth in tetracycline-free DME plus 10% CS for 16 h. Uninduced cells
were treated in the same manner in the presence of tetracycline. After this
pretreatment, the cells were detached from the plate with trypsin, washed
in the presence of soybean trypsin inhibitor, resuspended in DME plus
0.1% BSA in the presence or absence of tetracycline, and then loaded into
the top wells of a Boyden chamber at a concentration of 15,000 cells/well.
The bottom wells contained DME plus 0.1% BSA, with or without tetra-
cycline. The separating filter was coated on the underside only with 200
 
m
 
g/ml collagen, type I. The number of cells that successfully migrated
through the filter in three to six wells were counted after staining with he-
matoxylin.
 
Results
 
Establishment of Stable Cell Lines That Inducibly 
Express Pak1 and Rac1 Mutants
 
To assess the effects of Pak1 on motility, we established
stable cell lines in which Pak1 expression is regulated by
tetracycline. These cell lines included HA-tagged wild-
type, constitutive-active, and kinase-dead mutants of Pak1,
as well as Myc-tagged activated and dominant-negative
forms of Rac1 (Fig. 1 a). Two constitutive active forms of
Pak1, one that binds Cdc42/Rac normally (Pak1
 
E423
 
), and
one that does not (Pak1
 
L83,L86
 
), were included in order to
assess the role of p21 binding in
 
 
 
any
 
 
 
phenotypes induced
by Pak1 expression (Sells et al., 1997). Transgene expres-
sion was tightly controlled by tetracycline, displaying 5–10-
fold induction, as assessed by densitometry of anti-HA im-
munoblots (Fig. 1 b and data not shown). Importantly,
transgene expression was barely detectable in cells grown
in tetracycline-containing media, even on prolonged expo-
sure of immunoblots. As expected, immunoprecipitated
Pak1
 
E423
 
 displayed the most protein kinase activity, fol-
lowed by Pak1
 
L83,L86 
 
(Fig 1 c). Neither wild-type nor ki-
nase-dead forms of Pak1 displayed detectable kinase ac-
tivity, consistent with previous results (Manser et al., 1997;
Sells et al., 1997).
 
Expression of Mutant Forms of Pak1 Modulates Cell 
Morphology, F-Actin Distribution, and Focal Complex 
Formation in NIH-3T3 Clonal Cell Lines
 
We and others have previously shown that transient ex-
pression of Pak1 affects the structure of the actin cytoskel-
eton in Swiss 3T3 (Sells et al., 1997), HeLa (Manser et al.,
1997), and PC12 cells (Daniels et al., 1998). However, the
effects of stable Pak1 expression on populations of cells
have not been reported. Our tetracycline-regulatable cell
lines permit large numbers of cells to be examined, each
expressing similar levels of transgenic Pak1. In addition,
we can titrate the level of Pak1 expression by varying the
concentration of tetracycline. In induced NIH-3T3 cul-
tures, wild-type Pak1 has only modest effects on F-actin
distribution as we previously reported in transiently trans-
fected Swiss 3T3 cells (Sells et al., 1997), although dorsal
ruffles develop in a few (
 
,
 
20%) cells (Fig. 2 b). Expres-
sion of an activated Pak1 mutant, Pak1
 
L83,L86
 
, resulted in
formation of not only dorsal ruffles but also of large, asym-
metric lamellipodial structures characteristic of the lead-
ing edge of the cells (Fig. 2 c). These latter structures
resemble those found in motile fibroblasts. Interesting,
asymmetric lamellipodia were seen in 
 
.
 
50% of cells ex- 
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pressing another activated mutant, Pak1
 
E423 
 
(Fig. 2 d); the
remaining cells have a morphology characterized by a
marked loss of stress fibers and few lamellipodia similar to
those observed upon transient transfection (Manser et
al., 1997; Sells et al., 1997). That these differences are
due to the different cell types used for these studies is un-
likely, given that transient transfection of S2-6 cells with
pCMV6M-Pak1
 
E423
 
 (the same vector used in previous
studies with Swiss 3T3 cells; Sells et al., 1997), results in a
flattened, stress fiber-free cell phenotype (data not shown).
A more likely explanation for differences in cell morphol-
ogy may relate to the very high expression levels achieved
in transient transfection versus the more moderate, but
stable levels attained in the tetracycline-regulated cells. In
support of this latter hypothesis, when a small amount of
tetracycline (0.04 
 
m
 
g/ml) was added to the medium, the
population of cells as a whole produced lower levels of
Pak1
 
E423,
 
 with concomitantly higher percentage of the cells
having asymmetric lamellipodia as Pak1 production de-
creased (50.4% lamellipodia in tetracycline-free medium;
76.1% lamellipodia in medium containing 0.04 
 
m
 
g/ml tet-
racycline; 800 cells counted in total).
Expression of a kinase-dead form of Pak1 also induced
formation of lamellipodia, but, compared with cells ex-
pressing activated Pak1, these cells tended to have in-
creased numbers of such structures dispersed throughout
 
the cell body, giving the cells a multi-lobed appearance
(Fig. 2 e). Often, lamellipodia accumulated on multiple
sides of the cell, a phenotype that is virtually never ob-
served in cells expressing activated forms of Pak1.
To ensure that the NIH-3T3 derivatives used in these
studies respond to Rho-family GTPases like other com-
monly studied fibroblasts, we examined the cytoskeletal
effects of Rac1 in the parental S2-6 NIH-3T3 cells. As in
Swiss 3T3 (Ridley et al., 1992) and REF52 cells (Joneson
et al., 1996), activated Rac1 induced cell flattening and cir-
cumferential lamellipodia, formation of cortical focal com-
plexes, and a loss of central stress fibers (Fig. 2 f), while
the dominant-negative version induced compact but elon-
gated cells (data not shown). Thus, Rac1 expression gave
rise to phenotypes similar to those described previously in
Swiss 3T3 and REF52 cells, indicating that the S2-6 cells
behave in a similar manner as these well-described cell
systems.
 
The Morphologic Effects Produced by Overexpression of 
Pak1 in Fibroblasts Are Not Mediated by Rac1
 
We have previously argued that, in Swiss 3T3 cells, the ef-
fects of Pak1
 
L83,L86 
 
on F actin organization are independent
of Rac1 (Sells et al., 1997). However, Obermeier et al.
(1998) showed that Pak1
 
L83,L86 
 
induces neurite outgrowth
Figure 1. Tetracycline regulated expression of various forms of
Pak1 and Rac1 in NIH-3T3 clonal cell lines. (a) Structure and ac-
tivities of Pak1 and Rac1 mutants used in this study. A diagram-
matic representation of the wild-type and mutant forms of Pak1
and Rac1 are shown in the top panel with amino acid changes de-
noted by a single letter amino acid abbreviation of the mutant
residue. For Pak1, domains shown include the p21 binding
domain (PBD) and the catalytic domain (kinase). (b) Inducible
expression of Pak1 and Rac1 proteins. S2-6 NIH-3T3 cells, con-
taining the tTA transactivator, were transfected with tetracy-
cline-regulatable expression plasmids bearing either no insert
(control), or various forms of HA epitope–tagged Pak1 or Myc-
tagged Rac1. Pak1 constructs: wild-type, WT; constitutively acti-
vated, E423; kinase-inactive, R299; constitutively activated and
Cdc42/Rac-binding defective, L83,L86. Rac1 constructs: constitu-
tively activated, V12; and dominant-negative, N17. Stable clones
were isolated and characterized in both the presence and absence
of tetracycline (tet) for Pak1 expression by immunoblot with
anti-HA antisera, and for Rac1 expression by immunoblot with
anti-Myc antisera. (c) Protein kinase activity of induced cell lines.
HA-tagged Pak1 was immunoprecipitated from the indicated cell
lines and tested for auto-kinase activity. 
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in PC12 cells, and that 
 
z
 
40% of these effects are inhibited
by coexpression of a dominant-negative form of Rac1, im-
plying that Pak1 may operate upstream of Rac1. To reex-
amine this issue in fibroblasts, we transiently transfected
Rac1
 
N17 
 
into the tetracycline regulated cell line expressing
Pak1
 
L83,L86
 
. Cell expressing Pak1
 
L83,L86 
 
alone have, as ex-
pected, large asymmetric lamellipodia (Fig. 3 a, lower
cell). Coexpression of Rac1
 
N17
 
 has no apparent effect on
this phenotype (Fig. 3 a, upper cell). In cells that lack
Pak1
 
L83,L86
 
 expression (i.e., those grown in the presence of
tetracycline), Rac1
 
N17
 
 induces cell shrinkage, indicating
that this protein is biologically active (data not shown). To
quantitate these effects, we scored the phenotypes of 400
cells per group grown in the presence or absence of tetra-
cycline with or without coexpressed Rac1
 
N17
 
. As expected,
when grown in the presence of tetracycline, few cells dis-
play lamellipodia. Upon induction, 
 
z
 
91% of cells express-
ing Pak1
 
L83,L86
 
 alone, and 90% of cells coexpressing
Rac1
 
N17 
 
display characteristic lamellipodial structures (Fig.
3 b). A second activated Pak1 mutant, Pak1
 
E423
 
, was less
potent in inducing lamellipodia (56% of cells), but, as with
Pak1
 
L83,L86
 
, coexpression of Rac1
 
N17 
 
did not inhibit forma-
tion of these structures. The results of these studies show
that Rac1
 
N17
 
 has very little effect on the phenotype elicited
either by Pak1
 
L83,L86 
 
or Pak1
 
E423
 
, and therefore, in this cell
type, the effects of these activated Pak1 mutants on F actin
organization are independent of Rac1.
 
Expression of Pak1 Regulates Random
Cell Locomotion
 
Because the morphology induced by activated Pak1 mim-
ics that seen in motile fibroblasts, we investigated the role
 
of this enzyme in regulating cell movement. Although the
control of cell motility at the molecular level is poorly un-
derstood, it has been shown in a number of systems that
Ras, and related GTPases of the Rho family clearly play
important roles in this process (Ridley et al., 1995; Keely
et al., 1997; Sander et al., 1998). We assessed the effect of
Pak1 expression on cell motility by tracking the movement
of individual cells at 30-s intervals over a 1-h time course
after their attachment to fibronectin-coated dishes (Fig.
4). In the presence of tetracycline, the cell lines showed
minor differences in basal movement rate (16.51 
 
6 
 
0.85
nm/s for control cells, 12.49 
 
6 
 
0.66, 12.08 
 
6 
 
0.56, 14.67 
 
6
 
0.75, and 13.86 
 
6 
 
0.60 nm/s for wild-type Pak1, Pak1
 
L83,L86
 
,
Pak1
 
E423
 
, and Pak
 
1R299 
 
expressing cell lines, respectively;
Fig. 4). These differences probably reflect intrinsic clonal
variation. However, in the absence of tetracycline, the av-
erage control cell speed increased by only 0.24 nm/s, never
attaining the speed of Pak1-expressing cells, even though
these latter cells have a lower basal speed. In fact, the av-
erage speed of cells expressing wild-type Pak1, Pak1
 
L83,L86
 
,
Pak1
 
E423
 
, and Pak1
 
R299 
 
increased to 17.03 
 
6 
 
0.91, 17.58 
 
6
 
0.83, 21.06 
 
6 
 
0.88, and 23.25 
 
6 
 
1.07, respectively, when as-
sayed in the absence of tetracycline.
 
 
 
These data show that
increased Pak1 levels cause an increase in cell movement,
and that this increase is independent of protein kinase ac-
tivity.
 
Directional Cell Movement Is Affected by Pak1
Kinase Activity
 
Interestingly, although random cell motility is indepen-
dent of Pak1’s catalytic function, directional movement
strongly correlates with kinase activity. 4-h cell tracking
Figure 2. Expression of mutant forms of Pak1 mod-
ulates F-actin and vinculin distribution in cells of
NIH-3T3 clonal lines. Pak1 expression was induced
by growth in tetracycline-free DME plus 10% CS
for 8 h, followed by 16 h starvation in tetracycline-
free DME plus 0.1% CS. Confocal images are
shown. (a) control, (b) wild-type Pak1,  (c)
Pak1L83,L86, (d) Pak1E423, (e) Pak1R299 (arrows de-
note the three lamellipodia of a single cell), and (f)
Rac1V12. Cells were stained for F-actin (FITC-phal-
loidin, green), vinculin (anti-vinculin, visualized
with rhodamine X-labeled goat anti–mouse, red),
and Pak1 or Rac1 (anti-HA or anti-Myc, visualized
with Cy5-labeled goat anti–rabbit, blue). Bar, 25 mm. 
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experiments indicate that cells expressing kinase-dead
Pak1, though highly motile, display poor persistence of
movement compared with wild-type or activated forms of
Pak1 (Fig. 5). In contrast to cells expressing activated
Pak1, cells expressing kinase-dead Pak1 frequently and
abruptly change course. These effects are readily apparent
in cell path tracings (Fig. 6). Here, plots derived from the
paths of 10 randomly selected cells show that the overall
motility of cells expressing either activated or kinase-dead
Pak1 is increased, but that the complexity of the paths is
strongly related to protein kinase activity. Cells expressing
activated Pak1 move in relatively straight paths (Fig. 6, b
and d), whereas those expressing kinase-dead Pak1 move
randomly (Fig 6 f). We speculated that these different
types of movement, which are related to Pak1’s protein ki-
nase activity, might be reflected in other measurements of
directional motility. In agreement with this prediction,
cells expressing activated forms of Pak1 display increased
haptotactic movement in response to an immobilized col-
lagen gradient, whereas cells expressing kinase-inactive
Pak1 show slightly decreased haptotaxis (Fig. 7). As a con-
trol, we also assessed haptotaxis in Rac1-expressing cells.
Activated Rac1 enhances haptotactic movement, whereas
a dominant-negative form inhibits this directional move-
ment (data not shown). Interestingly, neither Pak1 nor
Rac1 affect chemotaxis towards soluble fibronectin (data
not shown and Anand-Apte et al., 1997), suggesting that
this signaling pathway is regulated by a different set of
proteins.
 
Pak1 Induces Phosphorylation of MLC at Serine 19
 
The activation of MLC by phosphorylation has been cor-
related with cell motility (Wilson et al., 1991, 1992;
Matsumura et al., 1998), perhaps due to its role in retract-
ing nondominant pseudopodia (Bailly et al., 1998b). Pak1
has been reported to affect myosin function in a variety of
organisms (Brzeska et al., 1996, 1997; Lee et al., 1996; Wu
et al., 1996), and mammalian Paks have been shown to
phosphorylate MLC at serine 19 in vitro (Ramos et al.,
1997; Chew et al., 1998; Van Eyk et al., 1998). We there-
fore asked whether Pak1 expression in fibroblasts results
in increased MLC phosphorylation. For these studies we
used an antibody that specifically recognizes the serine-19
phosphorylated form of MLC (Matsumura et al., 1998).
Lysates from control cells, or cells expressing WT, acti-
vated, or kinase-dead forms of Pak1 were examined by im-
munoblot for protein expression, MAPK and SAPK activ-
ity, and phospho-MLC content. These studies show that
activated forms of Pak1, like Rac1, induce activation of a
SAPK (Jnk) but not a MAPK (Erk1) pathway (Fig. 8).
These results are in agreement with most published stud-
ies, which show modest Jnk and p38 activation by acti-
vated forms of Pak (reviewed in Sells and Chernoff, 1997).
As expected, control cells treated with growth-stimuli such
as PDGF or LPA show Erk1 activation, while cells ex-
posed to a hyperosmotic shock show Jnk activation, dem-
onstrating that signaling pathways in the S2-6 cell lines are
generally similar to those observed in most other fibro-
blasts. Phospho-MLC is apparent in growth-factor treated
cells, as well as in cells expressing activated forms of Rac1
or Pak1, but not in control cells or cells expressing a ki-
nase-dead form of Pak1. These results indicate that acti-
vated Pak1 induces MLC phosphorylation and that this
phosphorylation is not mediated via downstream activa-
tion of Erk1.
Figure 3. Pak1-induced cytoskeletal changes are not mediated by
activation of Rac1. (a) Cells conditionally expressing activated
Pak1 were transfected with an constitutive expression vector for
a dominant-negative (N17) form of Rac1. Pak1 expression was
induced by growth in tetracycline-free DME plus 10% CS for 8 h,
followed by 16 h starvation in tetracycline-free DME plus 0.5%
CS. The cells were then fixed and stained for immunofluores-
cence. HA-tagged Pak1L83,L86 (blue), Myc-tagged Rac1N17 (red),
F-actin (green). Bar, 25 mm. (b) At least 400 cells expressing
Pak1 or Pak1 plus Rac1 were assessed for presence of lamellipo-
dia. Values represent combined data from three separate experi-
ments. 
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We also used the phospho-MLC antibody to localize ac-
tivated MLC by immunofluorescence. Cells inducibly ex-
pressing an activated form of Pak1 were grown in the pres-
ence or absence of tetracycline for 16 h before fixation.
These experiments show that cells expressing activated
forms of Pak1 induce an accumulation and localization of
phospho-MLC to the lamellipodia (Fig. 9). In nonexpress-
ing cells, phospho-MLC levels are low and are found
mainly in a perinuclear location (Fig. 9 a, left and right
panels). In Pak1-expressing cells, the amount of total
phospho-MLC is apparently significantly increased and a
substantial fraction of this protein now localizes just be-
neath the leading edge of lamellipodia (Fig. 9 b, left and
right panels). These results are consistent with a previous
study which showed that phospho-MLC accumulates in
lamellipodia in locomoting cells (Matsumura et al., 1998).
 
Discussion
 
The p21-activated kinases comprise a family of 62–68-kD
serine/threonine kinases. These enzymes are catalytically
activated by binding specifically to activated forms of
Cdc42 and Rac1, two GTPases of the Rho subfamily, thus
making Paks good candidate effectors for these signaling
molecules (Lim et al., 1996; Sells and Chernoff, 1997). In
fact, a number of the Paks have been implicated as the
downstream effectors for several Cdc42 and Rac1 regu-
lated signaling pathways including modulation of the actin
cytoskeleton and establishment of cell polarity (Cvrckova
et al., 1995; Marcus et al., 1995; Ottilie et al., 1995; Manser
et al., 1997; Sells et al., 1997), processes that are required
for cell motility. Although it has been shown recently that
both Cdc42 and Rac1 regulate motility and invasiveness of
epithelial cells (Hordijk et al., 1997; Keely et al., 1997),
and that Rac1 modulates growth factor–driven chemotaxis
in fibroblasts and macrophages (Anand-Apte et al., 1997;
Allen et al., 1998) whether any of the Paks play a role in
regulating these processes has not been established.
Pak1 has two types of effects on cell morphology, one
related to its protein kinase activity and one that is kinase
independent (Manser et al., 1997; Sells et al., 1997). We
and others have previously shown that at least some of
Pak’s kinase-independent effects on the actin cytoskeleton
are mediated by one or more SH3-containing proteins that
associate with proline-rich regions located in the NH
 
2
 
-ter-
minal half of Pak1 (Sells et al.; 1997, Daniels et al., 1998;
Obermeier et al., 1998). These SH3-containing proteins in-
clude, but are not necessarily limited to, the adaptor Nck
and the guanine-nucleotide exchange factor PIX and its
relatives (Bokoch et al., 1996; Galisteo et al., 1996; Lu et al.,
 
Figure 4. Cell motility is stimulated by Pak1. Pak1 expression
was induced by growth in tetracycline-free DME as described in
Methods. After protein induction, the cells were treated with
trypsin, washed in the presence of soybean-trypsin inhibitor, and
then replated in tetracycline-free DME plus 0.1% BSA onto
BSA-coated plates for 30 min. The cells were then transferred to
a fibronectin-coated plate and allowed to attach for 30 min. A
graphic representation of average speed of cells, expressed in
nm/s is shown. Cell movement was tracked at 30-s intervals using
Inovison Isee™ nano-tracking system. Results shown are repre-
sentative of four independent experiments. (Gray bars) Plus tet-
racycline; (black bars) minus tetracycline.The Journal of Cell Biology, Volume 145, 1999 844
Figure 5. Pak1 kinase activity affects character of movement. Pak1 expression was induced by growth in tetracycline-free DME as in
Fig. 4. After attachment to fibronectin-coated plates, individual cells were tracked. Phase contrast micrographs shown were taken at
30-min intervals. (a) control cells; (b) wild-type Pak1, (c) Pak1L83,L86, (d) Pak1E423, (e) Pak1R299 (the cell denoted by an arrow displayed
from two to four lamellipodia throughout the course of the experiment), (f) Rac1V12, and (g) Rac1N17. Arrows mark the track of a single
motile cell for each sample. Bar, 50 mm.Sells et al. Pak Regulates Cell Motility 845
1997; Bagrodia et al., 1998; Manser et al., 1998). Because
PIX is an activator of Rac1, Obermeier et al., have pro-
posed that the kinase-independent activity of Paks on ac-
tin polymerization is mediated by Rac1 (Obermeier et al.,
1998). In support of this model, they have shown that the
kinase-independent effects of Pak3 on neurite extension in
PC12 cells are partially inhibited by a dominant-negative
from of Rac1. In contrast, we have argued that, in microin-
jected Swiss 3T3 cells, the kinase-independent effects of
Pak1 are not inhibited by dominant-negative Rac1 (Sells
et al., 1997). Possibly, cell-type differences, or the isoforms
of Paks studied, account for these apparent discrepancies.
However, it should be noted that less than half of Pak3’s
effects in PC12 cells are blocked by dominant-negative
Figure 6. Pak1 kinase activ-
ity affects persistence of
movement. Pak1 expression
was induced by growth in tet-
racycline-free DME and the
cells plated and tracked as in
Fig. 5. The paths of ten
randomly-chosen cells were
plotted for each experimen-
tal group. The cells tracked
in a, c, and e were grown in
the presence of tetracycline;
those in b, d, and f  were
grown in the absence of
tetracycline. (a and b)
Pak1L83,L86, (c and d)
Pak1E423, and (e and f) Pak1R299.
Distance traversed from the
origin is graphed in mm, with
each hashmark representing
30  mm.The Journal of Cell Biology, Volume 145, 1999 846
Rac1, that a nearly identical degree of inhibition is seen in
control cells, and that dominant-negative Cdc42 has an
even more inhibitory effect (Obermeier et al., 1998).
Therefore, it is not clear if or how Pak3 functionally links
Cdc42 to Rac1. Whatever the situation in PC12 cells, our
present data show that dominant-negative Rac1 has no
measurable effect on Pak1-driven actin reorganization in
NIH-3T3 cells. Therefore, at least in cells of mesenchymal
origin, the kinase-independent effects of Pak1 do not re-
quire Rac1.
As with cell morphology, the effects of Pak1 on cell
movement also have a kinase-dependent and independent
component. Overexpression of wild-type or mutant forms
of Pak1 all increase cell movement, but protein kinase ac-
tivity affects the persistence of these movements. Cells ex-
pressing kinase-dead Pak1 are characterized by multiple,
randomly arrayed, lamellipodia, that continuously form
and recycle. These cells move more quickly than controls,
but do so in a haphazard manner, frequently and abruptly
switching direction. In contrast, cells expressing wild-type
or activated forms of Pak1 are characterized by a single
lamellipodium at the leading edge. These cells move more
quickly than controls, and also display increased persis-
tence. As with activated Cdc42 and Rac1 (Keely et al.,
1997), such cells also display increased haptotaxis towards
a collagen gradient. These differences are likely to reflect
the failure of cells expressing kinase-dead Pak1 to polarize
F-actin appropriately. It is also possible that the increased
motility of these cells is related to weakened adhesion to
the substratum, as activated Pak1 induces aberrant forma-
tion of focal adhesion complexes (Allen et al., 1997; Manser
et al., 1997).
The formation of membrane extensions such as pseu-
dopodia is thought to be driven mainly by actin polymer-
ization (Condeelis, 1993; Mitchison and Cramer, 1996).
This process is evident in cells expressing either kinase-
dead or kinase-active versions of Pak1. As mentioned
above, these effects are likely to be mediated by interac-
tions between the NH2-terminal, non-catalytic, domain of
Pak1 and other proteins that affect actin polymerization.
Although our data argue against the possibility that Rac1
acts downstream of Pak1, it is possible that other GTPases
that affect actin organization, such as Arf6, might be acti-
vated by Pak1 (Radhakrishna et al., 1999). Activation of
this or a similar GTPase might account for the kinase-
independent ruffling induced by Pak1. Actin polymeriza-
tion by itself, however, is insufficient for directed cell
movement. In gradient-directed cell movement, one or
more pseudopodia become dominant, while the others are
suppressed, and these dominant pseudopodia are stabi-
lized as leading edge lamellipodia, whose firm attachment
to the substratum are thought to provide an anchorage
point for contractile forces. The process of selection, gen-
eration, and propagation of a leading edge lamellipodium
from a group of random pseudopodia is poorly under-
stood, but may involve stabilization of filaments through
the formation of strong focal contacts. In addition, nonad-
herent extensions may be actively suppressed once a lead-
ing edge lamellipodium is established (Bailly et al., 1998a;
Wyckoff et al., 1998). In NIH-3T3 cells, expression of acti-
vated, but not kinase-dead, Pak1 results in large, polarized
lamellipodia and persistent cell movement. Phospho-MLC
is increased, both in the trailing edge and at the leading
edge of the motile cells. A similar distribution has been
noted previously in other motile cells (DeBiasio et al.,
1996; Matsumura et al., 1998). Phosphorylation at the tail
is thought to be responsible for pushing the cell body for-
ward by tail contraction. The function of phosphorylated
MLC at the leading edge is less clear, but may contribute
to the membrane extensions at the leading edges, either by
translocating actin filaments to this location or by sup-
pressing lamellipodia formation in the absence of the rein-
forcement provided by stable focal contact (Goeckeleer
Figure 7. Pak1 kinase activity affects haptotaxis. Cells loaded
into the top wells of a modified Boyden chamber and allowed to
migrate in response to an immobilized collagen gradient. 18 h
post-loading, the number of cells that traversed the membrane
was quantified. Results shown are representative of three inde-
pendent experiments, and are normalized to the results obtained
for cells grown in the presence of tetracycline 6 SE.
Figure 8. Activated Pak1 induces MLC phosphorylation in the
absence of MAPK activation. Control NIH-3T3 cells or NIH-3T3
cells expressing various forms of Pak1 were starved overnight in
media containing 0.5% CS, then treated with the indicated com-
pounds (PDGF, 10 ng/ml or LPA 5 mg/ml) for 10 min. Immu-
noblots of cell lysates were probed with anti-HA (to detect
transgene expression), and antibodies against the activated
(phosphorylated) forms of Jnk, Erk, and MLC.Sells et al. Pak Regulates Cell Motility 847
and Wysolmerski, 1995; Welch et al., 1997; Bailly et al.,
1998a; Matsumura et al., 1998; Wyckoff et al., 1998). Ac-
cording to this scenario, active Pak1 may concentrate at
the incipient leading edge in resting cells, perhaps directed
there by the exchange factor PIX, where it acts upon myo-
sin II, augmenting the polarity of the cell. This might ex-
plain the effects of active Pak1 on directional cell move-
ment. Whatever the exact function of myosin II in
locomoting cells, our data are consistent with the notion
that Pak1 has two types of effects on cell morphology and
motility; a kinase-independent activity that affects actin
polymerization, and a kinase-dependent function that in-
creases phospho-MLC levels and stabilizes leading edge
lamellipodia.
How does Pak1 affect the phosphorylation state of the
MLC? The effect of Pak1 on MLC may be direct, as Pak1
has been shown to phosphorylate serine 19 of the MLC in
vitro (Ramos et al., 1997; Chew et al., 1998; Van Eyk et al.,
1998). Alternatively, Pak1 might induce MLC phosphory-
lation indirectly, via activation of MAPK or Rho kinase,
both of which affect MLC kinase activity (Amano et al.,
1996; Klemke et al., 1997). Although Paks are usually con-
sidered to be activators of SAPKs such as Jnk and p38,
rather than of MAPKs such as Erk1 and -2 (Kyriakis and
Avruch, 1996; Sells and Chernoff, 1997), Pak2 has recently
been shown to phosphorylate Raf-1 (King et al., 1998).
(The Pak isoform that phosphorylates Raf is actually
Pak2, not Pak3 as stated in King et al., 1998. This error in
nomenclature can be traced to mistakes in the GenBank
annotations for g-Pak, which is also known as Pak2 [see
Sells and Chernoff, 1997].) This phosphorylation is re-
quired for efficient Raf-1 activation. In addition, Pak1
phosphorylates MEK on serine 298, increasing its affinity
for its activator, Raf-1 (Frost et al., 1997). These data
suggest that Pak1 activity positively regulates the MAPK
pathway. As activation of MAPK is associated with in-
creased MLC phosphorylation and cell movement (Klemke
et al., 1997), this pathway might explain Pak1’s effects on
motility. However, in our inducible cell lines, neither wild-
type nor mutant forms of Pak1 appreciably stimulate Erk1
or -2, while activated forms do modestly activate Jnk.
Therefore, activation of MLC via MAPKs cannot explain
our findings. Alternatively, since Pak1 is associated with
PIX, a guanine-nucleotide exchange factor for Rac1
(Manser et al., 1998), Pak1 might activate Rho kinase
through a GTPases cascade (Cdc42 to Rac1 to RhoA)
(Nobes and Hall, 1995). However, coexpression of a domi-
nant-negative form of Rac1 did not interfere with Pak1-
induced cell polarity changes, making it unlikely that its
motility effects are mediated through a known GTPase
cascade. Therefore, if Pak2 activates Rok, it is not likely
via downstream activation of Rac1 and RhoA. In this re-
gard, it is interesting to note that fission yeast Pak1p has
recently been shown to operate upstream of the Rok ho-
mologue Orb6p (Verde et al., 1998). Whether fission yeast
Rho1p is interposed between Pak1p and Orb6p is not
known, but these data do reinforce the notion that some of
Pak’s effects on myosin phosphorylation might be medi-
ated by Rok. Therefore, at present we are uncertain if
Pak1 directly phosphorylates MLC or does so indirectly
through Rho, Rok, and/or MLCK. These possibilities may
be distinguishable through the use of C3 toxin or domi-
nant-negative forms of RhoA or Rok.
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